Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Abaxis Inc. (NASDAQ: ABAX) cut to Underperform from Neutral. Activision Blizzard Inc. (NASDAQ: ATVI)…
Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Apache Corp. (NYSE: APA) cut to Neutral at Macquarie. Bank of America Corp.…
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you…
The largest biotech stocks have been great performers in 2012. The question is whether that can be sustained in 2013. If Wall St. analysts are correct, biotech and biohealth investors are going…
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for…
ThinkstockInsider selling is starting to get massive before year-end when higher capital gains taxes will kick in. We continue to expect that corporate insiders, venture backers, private equity backers, and founders will…
The stock market is mixed Wednesday, with the Dow Jones Industrial Average up 0.06%, the Nasdaq down 0.03% and the S&P 500 up 0.11%. Today’s winners are two pharmaceutical companies, one getting…
247sam Fortune is out with its top 10 stock picks for 2013. The list was divulged on CNBC late on Wednesday afternoon and was based on a survey of fund managers based upon…
The list of the best stocks of 2012 on the S&P 500 Index is one which makes sense in some cases and doesn’t in other cases. Some of these are simply recovery…
The stock market is down Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq down 0.02% and the S&P 500 down 0.01%. Today’s winners include two companies getting bought out…
ThinkstockWhen biotech stocks become as big as some of the second-tier drug stocks, it represents billions of dollars worth of value when these move 5% or 10%. That is exactly what we…
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from…
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement…
